| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.35 | 0.05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |